PLGA (50:50)
PLGA (50:50) (poly (lactic-co-glycolic acid) (50:50) ) is a copolymer of poly lactic acid (PLA) and poly glycolic acid (PGA) which can be used to fabricate devices for drug delivery and tissue engineering applications.
Product Specifications
CAS Number
34346-01-5
Product Name Alternative
Poly (lactic-co-glycolic acid) (50:50)
UNSPSC
12352211
Target
Biochemical Assay Reagents
Type
Oligonucleotides
Related Pathways
Others
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/plga-50-50.html
Purity
99.0
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(O)C(C)OC(CO[H])=O.[x].[y]
Molecular Formula
(C3H6O3) n. (C2H4O3) n
Molecular Weight
10000-20000
References & Citations
[1]Makadia HK, et al. Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier. Polymers (Basel) . 2011 Sep 1;3 (3) :1377-1397.|[2]Chung TW, Tsai YL, Hsieh JH, Tsai WJ. Different ratios of lactide and glycolide in PLGA affect the surface property and protein delivery characteristics of the PLGA microspheres with hydrophobic additives. J Microencapsul. 2006;23 (1) :15-27. |[3]Mura S, et al. Influence of surface charge on the potential toxicity of PLGA nanoparticles towards Calu-3 cells. Int J Nanomedicine. 2011;6:2591-605.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PKSM041326-01 10 µg
Recombinant Mouse IMPAD1/IMP3 Protein (His Tag)
Sign In for Pricing
View Details PKSM041326-02 50 µg
Recombinant Mouse IMPAD1/IMP3 Protein (His Tag)
Sign In for Pricing
View Details 
BNC402354-100 1x 100 µL
FOLH1 / PSMA (Prostate Epithelial Marker) (FOLH1/2354), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC941798-500 1x 500 µL
Ep-CAM / CD326 (Extracellular Domain) (Epithelial Marker) (EGP40/1798), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
